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Abstract
Background: The aim of this study is to clarify the following two points: First, whether a cyclooxygenase-2
mediated pathway is involved in the formation of immobilization-induced joint contracture and, second, the
effectiveness of oral administration of non-steroidal anti-inflammatory drug celecoxib (CBX) for the prevention of
myogenic and arthrogenic contracture following immobilization in a rat model.
Methods: Thirty male rats were randomly divided into three groups: immobilization (Im), Im + CBX, and control
(n = 10 each). External fixation immobilized the right knee joint of Im and Im + CBX groups in flexion for 3 weeks.
50 mg/kg of CBX was administrated daily to the Im + CBX group during this period. The passive range of motion
(ROM) of knee joints was measured before and after transection of knee flexor muscles and myogenic and
arthrogenic ROM restrictions were calculated. The semitendinosus muscles and knee joints were investigated
histologically to elucidate factors responsible for contracture.
Results: Myogenic ROM restrictions were exhibited both in Im and Im + CBX groups (44 ± 5 and 36 ± 8 °, respectively),
but restrictions significantly decreased in the Im + CBX group compared to the Im group. Significant reductions of the
muscle length ratios (Rt/Lt) and sarcomere number ratios (Rt/Lt) in knee flexor semitendinosus muscle, which are
responsible for myogenic contracture, were also seen both in Im group (92 ± 5 and 92 ± 4 %, respectively) and
Im + CBX group (97 ± 3 and 97 ± 3 %, respectively), but were inhibited by CBX administration (P < 0.05). Im and
Im + CBX groups exhibited arthrogenic ROM restrictions with no significant differences (82 ± 3 and 83 ± 5 °,
respectively). Posterior synovial length shortening and pathological changes (hemorrhage in joint cavities and
capsule edema) in the knee joints were comparable between Im and Im + CBX groups.
Conclusions: Oral administration of celecoxib partially reduced myogenic ROM restriction concomitantly with knee
flexor muscle shortening following immobilization. These results imply that inflammation and nociception are involved
in myogenic contracture formation independently of joint immobilization, and that CBX is effective in preventing joint
contracture following immobilization in rats.
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Background
The development of joint contractures is induced by a
variety of events such as immobilization [1–6], joint sur-
gery or trauma [7], muscle weakness, and neurological
dysfunction such as paralysis and spasticity [1, 8]. These
events accompany joint inactivity and suggest that joint
immobilization is essentially a trigger for contracture
formation. If movement of the affected joint is permit-
ted, passive movements (e.g., stretching, continuous
passive motion, and splinting) are the most common in-
terventions for the treatment and prevention of joint
contractures [1]. However, the efficacy of passive move-
ment is still controversial. A systematic review revealed
that dynamic splints, which provide prolonged passive
stretching, is a safe and effective treatment for contrac-
ture in humans and animals [8]. On the other hand,
Prabhu et al. [9] reviewed that it is not clear whether
passive movements are effective for the treatment and
prevention of contractures. Katalinic et al. [10] also con-
cluded that stretching does not have an important effect
on joint mobility. These results imply the need for the
development of new alternative methods for the treat-
ment of joint contractures.
In a recent study, we found that contracture is gener-
ated in arthritic knee joints with only a slight, transient
reduction in active joint range of motion (ROM) during
locomotion [11, 12]. This result indicates that joint
contracture is not necessarily associated with joint
immobilization. Interestingly, joint immobilization leads
to not only contracture, but also joint inflammatory
conditions characterized by synovitis [13] and an upregu-
lation of inflammation-related genes [14]. In addition,
arthritis-induced contracture is partially prevented and
improved by anti-inflammatory drugs [15–17]. As such,
anti-inflammatory treatment may prevent immobilization-
induced contracture as well as arthritis-induced
contracture. However, investigation into the effects of
anti-inflammatory drugs on immobilization-induced
joint contracture is very limited. Michelsson et al. [18]
reported that administration of corticosteroid methyl-
prednisolone has a preventive effect on joint stiffening,
but only in the beginning of the immobilization period
(<5–6 weeks). After this, ROM restriction proceeded
despite remobilization of the rabbit knees. It was also
shown that the administration of ibuprofen, a non-steroidal
anti-inflammatory drug (NSAID), does not suppress the
formation of joint stiffening in immobilized rabbit knees
[19]. However, ROM analysis was only carried out semi-
quantitatively, and more importantly, the report did not
distinguish between the contributions of muscular and ar-
ticular factors on contracture formation; the factors respon-
sible for joint contracture are divided into mainly muscular
and periarticular structures [4, 20]. Intra-articular injection
of high molecular weight hyaluronan, which modulates
inflammatory response, could prevent fibrotic changes in
immobilized joint capsules in rats [21] and rabbits [22].
However, they did not evaluate myogenic ROM restriction
and focused not on muscular but on articular factors in the
contribution of contracture. Thus, the effects of anti-
inflammatory drugs on myogenic and arthrogenic contrac-
ture formation have not been yet concluded.
In this study, we selected celecoxib (SC-58635; 4-[5-(4-
methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] ben-
zenesulfonamide), a selective cyclooxygenase (COX)-2
inhibitor, as the anti-inflammatory drug. Celecoxib has
been widely used to treat pain and inflammation via sup-
pression of prostaglandin E2 synthase [23]. The aim of this
study is to clarify the following two points: First, whether
a COX-2 mediated pathway is involved in the formation
of immobilization-induced joint contracture and,
second, the effectiveness of NSAID celecoxib for the
prevention of myogenic and arthrogenic contracture
following immobilization in a rat model.
Methods
Animals
Eight-week-old male Wistar rats (30 animals, 199 ± 3 g,
Japan SLC, Shizuoka, Japan) were used in this study.
The animals were housed in standard cages, given access
to food and water ad libitum, and maintained in a
thermoneutral environment (22–25 °C) with a 12-h
light-dark cycle.
Joint immobilization
Joint immobilization was conducted using the external
fixation method, as described previously [24]. Under
anesthesia with an intraperitoneal injection of sodium
pentobarbital (0.5 mL/kg), Kirschner wires were screwed
into the femur and tibia of the rat’s right hindlimbs and
subsequently fixed by wire and resin at 140 ° knee
flexion for 3 weeks (Fig. 1). Joint immobilized rats were
divided into two groups: immobilization (Im) (n = 10)
and immobilization with celecoxib administration (Im +
CBX) (n = 10). Celecoxib (50 mg/kg orally) was adminis-
trated daily to the Im + CBX group during the 3 week
immobilized period. Age-matched untreated animals
were used as the control group (n = 10).
ROM measurement
At the end of the intervention period, passive knee joint
ROM was measured as described previously [12]. Rats
were anesthetized with sodium pentobarbital (0.5 mL/kg)
with supplemental diethyl ether inhalation to inhibit
muscle contraction completely, if necessary. After remov-
ing an external fixator and exfoliating of skin of the hind-
limb, color markers were placed corresponding to the
greater trochanter, knee lateral joint space, and lateral
malleolus. The femur was fixed at approximately 90 ° hip
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flexion, and 14.6 N·mm extension moments were applied
to the knee joint. Knee joint ROM was measured using a
3D motion analysis system KinemaTracer (KISSEI COM-
TEC, Nagano, Japan) and three video cameras (Tokina,
Tokyo, Japan). The markers in the filmed image were
traced. The KinemaTracer software used to analyze the
coordinates was calibrated by recording a cube of known
size. The angles between the axes of the femur (the greater
trochanter to the knee lateral joint space) and fibula (the
knee lateral joint space to the lateral malleolus) were mea-
sured as the knee extension ROM (ROM+m). After the
ROM+m measurement, rats were sacrificed by exsanguin-
ation under inhalation of diethyl ether. The knee flexor
muscles, except for the semitendinosus muscles, were
completely transected at the mid-belly portion. As for the
semitendinosus muscle, the ischium tuberosity attached to
the tendon was removed from the hip bone. After exclud-
ing myogenic factors in flexion contracture, knee exten-
sion ROM (ROM-m) was measured again as detailed
above. All measurements were performed on both sides of
the knee in all groups.
Myogenic ROM restriction was defined as contracture
due to knee flexor muscle components, and arthrogenic
ROM restriction was defined as contracture due to ar-
ticular components such as bone, cartilage, synovium,
subsynovium, capsule, and ligaments. These ROMs were
calculated using the methods of Moriyama et al. [25].
The formulas are as follows:
Myogenic restriction ¼ ROM−m – ROMþm
within each treatment groupð Þ
Arthrogenic restriction ¼ ROM−m of control group – ROM−m
of each treatment group:
Tissue preparation
After the ROM measurement, the semitendinosus mus-
cles attached to the bones (ischium and tibia), were im-
mediately removed from both hindlimbs. The distal end
of the muscles were fixed and the proximal end was
connected to 16 g of weight to stretch them with a
uniform force using a pulley in 0.1 M phosphate-
buffered 4 % paraformaldehyde (pH 7.4) for 4 h at room
temperature. The weight was determined beforehand as
the same force required for the knee joint extension at
140 °, which is approximately the maximal extension
ROM in a normal joint. After fixation, muscle length
was measured using manually operated calipers
(Mitutoyo Instruments, Yokohama, Tokyo) and the mid-
belly portion of muscles was dissected and embedded in
paraffin. Longitudinal sections (4-μm) were cut and
stained with hematoxylin and eosin (HE) for microscopic
observation.
Joint tissues were also dissected and immersion-fixed
in the same fixative for 2 days at 4 °C to investigate knee
joint pathology. During fixation, the knee joint angle was
kept at 90 ° flexion. Joint samples were decalcified in
17.7 % ethylendiamintetraacetic acid (pH 7.2, OSTEO-
SOFT, Merck Millipore, Darmstadt, Germany) for 4 weeks
at room temperature, cut into two pieces on the sagittal
plane, and embedded in paraffin. The sections (4-μm)
were cut at the central level of the medial condyle and
stained with HE and aldehyde-fuchsin-Masson Goldner
(AFMG) staining for histological study.
Histological and histomorphometrical analysis
The semitendinosus muscles
Three portions from each HE section were photo-
graphed at a magnification of 20x with a digital camera
mounted on a light microscope to visualize sarcomeres.
Ten muscle fibers from each sample were randomly
selected and the myofibril lengths were measured using
Image J 1.48 software (National Institutes of Health,
Bethesda, MD, USA). The number of serially arranged
sarcomeres, including the length-measured myofibrils
was counted and the average sarcomere lengths were
calculated. In addition, the number of serially arranged
sarcomeres, including the whole muscle, was calculated
by dividing the muscle length by sarcomere length and
expressing it as a total sarcomere number.
Fig. 1 Photograph of joint immobilization. Knee joint is immobilized
by an external fixator at approximately 140 ° flexion (the angle
between the femur and the tibia is 40 °)
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Knee joint hemorrhage score
Intra-articular hemorrhages were detected through
microscopic observation in the knee joints in both Im
and Im + CBX groups. Two observers unaware of the
source of the samples evaluated joint hemorrhage sever-
ity. Severity of the hemorrhage was graded from 0 to 4
depending on the amount of infiltrated blood-derived
cells: 0 = none, 1 = slight, 2 = moderate, 3 = severe, and
4 = more severe. The antero-superior, antero-inferior,
postero-superior, and postero-inferior portions of joint
cavities were graded separately. The sum of these in-
dividual scores averaged for the two observers was
used as the representative score for each portions.
Joint capsule length
The length of the postero-superior and postero-inferior
synovial membrane were measured using the image ana-
lysis software ImageJ according to the methods described
by Ando et al. [26]. The measurements were summed to
provide a total synovial membrane length. Shortened pos-
terior synovial length is thought to be responsible for knee
joint contracture in a rat immobilization and spinal cord
injury model [25, 27, 28].
Statistical analysis
All data were expressed as mean ± standard deviation
(SD). Statistical analysis was performed using Dr.
SPSS II for Windows (SPSS Japan Inc, Tokyo, Japan).
For all data except for the hemorrhage score, one-way
analysis of variance (ANOVA) and Tukey’s post-hoc
test were applied. For the hemorrhage score, a non-
parametric Kruskal-Wallis test was applied, followed
by a Mann-Whitney test with the Bonferroni adjust-




Knee extension ROMs before myotomy (ROM+m) and
after myotomy (ROM-m) of knee flexor muscles on both
sides are shown in Fig. 2. The ROM+m on the experi-
mental (Rt) side were 145 ± 5, 88 ± 4, and 102 ± 9 ° in
the control, Im, and Im + CBX groups, respectively
(Fig. 2a). The ROM+m on the experimental side
decreased in both Im and Im + CBX groups compared
to each contralateral (Lt) side and the control group
(P < 0.0005, F = 240.9, ηP
2 = 0.95, one-way ANOVA; all
P < 0.05, Tukey’s post hoc test). In comparing the two
immobilized groups, ROM +m of the Im + CBX group
was larger than the Im group (P < 0.05, Tukey’s post
hoc test). The ROM-m on the experimental side were
160 ± 7, 132 ± 5, and 137 ± 9 ° in the control, Im, and
Im + CBX groups, respectively (Fig. 2b). The ROM-m
on the experimental side also decreased in both Im
and Im + CBX groups compared to each contralateral
side and the control group (P < 0.0005, F = 41.7, ηP
2 =
0.75, one-way ANOVA; all P < 0.05, Tukey’s post hoc
test). Contrary to the result in ROM+m, there was no
difference in ROM-m between the Im and Im + CBX
groups (P = 0.38, Tukey’s post hoc test).
Myogenic ROM restrictions were 15 ± 6, 44 ± 5 and
36 ± 8 ° in the control, Im, and Im + CBX groups, re-
spectively (Fig. 3a). The myogenic ROM restrictions
were significantly larger in both Im and Im + CBX
groups compared to the control (P < 0.0005, F = 60.4,
ηP
2 = 0.81, one-way ANOVA; both P < 0.05, Tukey’s
post hoc test), and myogenic ROM restriction in the
Im + CBX group was smaller than in the Im group
(P < 0.05, Tukey’s post hoc test). Arthrogenic ROM
restrictions were 0 ± 8, 30 ± 5, and 27 ± 8 ° in the
control, Im, and Im + CBX groups, respectively
(Fig. 3b). Arthrogenic ROM restrictions in the Im
A
B
Fig. 2 Histograms showing changes in passive knee extension ROMs.
a ROM before myotomy of knee flexor muscles (ROM+m). Joint
immobilization induced ROM+m restrictions in both Im and Im + CBX
groups. Celecoxib partially prevented the ROM+m restriction induced
by joint immobilization. b ROM after myotomy of knee flexor muscles
(ROM-m). Joint immobilization induced ROM-m restrictions in both Im
and Im + CBX groups. Celecoxib did not change ROM-m restriction
induced by joint immobilization. (Experimental side (Rt), ■; Contralateral
side (Lt), □). †P< 0.05 vs. contralateral side of the same group; #P< 0.05
vs. ipsilateral side of Im group. Data are expressed as means ± SD (n= 10)
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and Im + CBX groups were also significantly larger
compared to the control (P < 0.0005, F = 54.3, ηP
2 = 0.80
for the ANOVA; both P < 0.05 for the Tukey’s post hoc
test). There was no difference in arthrogenic ROM re-
striction between the Im and Im + CBX groups.
Muscle length, sarcomere length, and serial number
The semitendinosus muscle length, sarcomere length,
and serial number are shown in Table 1. Muscle length
on the experimental side decreased in both the Im and
Im + CBX groups compared to each contralateral side
and the control (P < 0.05). The muscle length ratios
(experimental side/contralateral side) of the two immo-
bilized groups were significantly decreased compared to
the control. Between the two immobilized groups, the
muscle length ratio of the Im + CBX group was larger
than the Im group (P < 0.05, Fig. 4a). Changes in sarco-
mere number were similar to those in muscle length ra-
tio (Fig. 4b), but there were no differences in sarcomere
length among the three groups (Table 1).
Joint histology and histomorphometry
In the semitendinosus muscles, muscle fibers were or-
derly arranged and apparent signs of inflammation were
hardly observable in all three groups.
Representative images of the posterior capsule of the
knee joint in HE sections are shown in Fig. 5a-f. In the
control group, the joint capsule was thin and densely
stained. Infiltrated cells were scarcely seen throughout
the knee joint tissue (Fig. 5a, d). In AFMG sections, pos-
terior joint capsules were densely stained green, indicat-
ing collagen fibers. In both Im and Im + CBX groups,
the posterior capsules were thickened with edema and
stained pale-green in AFMG sections. Fibrotic changes
characterized by increased collagen deposition was not ap-
parent in both Im and Im+CBX groups. Blood-derived
cells (mainly red blood cells) had increased, especially in
postero-superior portions near the synovial-cartilage junc-
tion in the knee joint cavities. Inflammatory infiltrates
were rarely seen in posterior joint capsules (Table 2,
Fig. 5b, c, e, f ). These pathological changes were approxi-
mately comparable between Im and Im +CBX groups.
Mean hemorrhage scores showed a significant increase in
both Im and Im+CBX groups compared to the control
A
B
Fig. 3 Histograms showing changes in knee extension ROM restriction.
a Myogenic restrictions. Celecoxib treatment partially reduced myogenic
contracture induced by joint immobilization. b Arthrogenic restriction.
Celecoxib treatment did not reduce arthrogenic contracture induced by
joint immobilization. *P < 0.05 vs. control group; #P< 0.05 vs. Im group.
Data are expressed as means ± SD (n= 10)
Table 1 Semitendinosus muscle length, sarcomere length, and serial sarcomere number
Group Muscle Sarcomere
Length (mm) Rt/Lt ratio (%) Length (μm) Rt/Lt ratio (%) Number Rt/Lt ratio (%)
Control Rt 51.1 ± 1.3 101 ± 3 2.7 ± 0.2 101 ± 3 20016 ± 691 99 ± 2
Lt 50.8 ± 1.5 2.7 ± 0.2 20165 ± 625
Im Rt 46.4 ± 2.1* 92 ± 5† 2.7 ± 0.1 98 ± 4 16892 ± 316* 92 ± 4†
Lt 50.8 ± 0.6 2.8 ± 0.1 18047 ± 505
Im + CBX Rt 46.6 ± 0.9* 97 ± 3†§ 2.8 ± 0.1 98 ± 4 16933 ± 316* 97 ± 3†§
Lt 49.1 ± 0.8 2.8 ± 0.1 17291 ± 155
Values are shown as means ± SD
*indicates significant difference from contralateral (Lt) side (P < 0.05)
†indicates significant difference from Control (P < 0.05)
§indicates significant difference from Im (P < 0.05)
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(P < 0.05), but there was no difference between the Im and
Im+CBX groups (Fig. 5g).
The postero-superior synovial lengths were 6.2 ±
1.0 mm, 3.8 ± 0.5 mm (P < 0.05), and 3.61 ± 0.3 mm
(P < 0.05) in the control, Im, and Im + CBX groups,
respectively. The postero-inferior synovial lengths
were 1.6 ± 0.2 mm, 0.8 ± 0.2 mm (P < 0.05), and 0.8 ±
0.3 mm (P < 0.05), and the total lengths of the poster-
ior synovial membrane were 7.7 ± 1.1 mm, 4.6 ±
0.5 mm (P < 0.05), and 4.4 ± 0.3 mm (P < 0.05) in the
control, Im, and Im + CBX groups, respectively. The
posterior synovial membranes in the Im and Im +
CBX groups were significantly shorter compared to
the control (Fig. 5h). However, there was no differ-
ence between the two immobilized groups in any of
the synovial length parameters.
Discussion
The key finding of the present study is that the COX-2
inhibitor celecoxib can partially prevent myogenic con-
tracture by acting on knee flexor muscles following joint
immobilization. However, arthrogenic contracture could
not be inhibited by celecoxib treatment due to changes
in articular components. These results indicate that the
COX-2 mediated pathway, which is involved in inflamma-
tion and nociception, contributes to the formation of myo-
genic contracture independently of joint immobilization.
This study is therefore the first to provide the beneficial
effects of NSAID on the prevention of immobilization-
induced joint contracture.
The passive extensibility of skeletal muscle is deter-
mined by several anatomic and physiologic properties,
with maximal muscle length being one important deter-
minant of joint ROM [1, 29]. In this study, we demon-
strated that the length of semitendinosus muscles in
immobilized knee joints shortened resulting from a re-
duction in sarcomere number. This is in accordance
with previous reports [29]. These changes were attenu-
ated by celecoxib treatment concomitantly with myo-
genic ROM restriction. These results suggest that the
COX-2 mediated pathway is involved in the regulation
of muscle length by changing sarcomere number in the
immobilized joint. The COX-2 also regulates skeletal
muscle regeneration [30, 31], hypertrophy [32], and
recovery from atrophy [33]. Passive extensibility is influ-
enced by muscle size [29]. However, the effects of COX-
2 inhibitor on muscle atrophy following immobilization
is unknown. Further study on muscle atrophy may eluci-
date the mechanisms behind CBX-mediated attenuation
of muscular contracture.
In guinea pigs, muscle contraction in a shortened pos-
ition accelerates the reduction in extensibility with
sarcomere loss [34]. Huet de la Tour et al. [35] also re-
ported that spasm of soleus muscles elicit a decrease in
passive extensibility and a marked reduction of sarco-
mere number in guinea pigs. These results suggests that
muscle contraction in a shortened position is key in the
determination of muscle length. In addition, knee joint
nociception also induces involuntary muscle contraction
in biceps femoris muscles [36]. Several reports indicate
that joint immobilization induces inflammatory condi-
tions within affected joints, such as an increase in joint
breadth [19], synovial cell proliferation, and mono-
nuclear infiltration [13], as well as an upregulation of
inflammatory cytokines [14]. In addition, we found
pathological changes such as blood cell infiltration into
intracapsular spaces and joint capsule edema in Im and
Im + CBX groups. Interestingly, it has been reported that
COX-1 and COX-2 are upregulated in synoviocytes and
chondrocytes in immobilized rat knee joints [37].
Celecoxib inhibits prostaglandin E2 synthase, mediated
by COX-2, and relieves pain [23]. Taken together,
successful celecoxib treatment for alleviating myogenic
contracture may be due to inhibition of the reduction in
sarcomere number and muscle length via inhibition of
A
B
Fig. 4 Histograms showing morphological changes in the semitendinosus
muscles. aMuscle length ratio (experimental side (Rt)/contralateral side
(Lt)). b Sarcomere number ratio (experimental side (Rt)/contralateral side
(Lt)). Decrease in both muscle length ratio and sarcomere number ratio
were partially prevented by celecoxib treatment. *P<0.05 vs. control
group; #P<0.05 vs. Im group. Data are expressed as means ± SD (n=10)
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the COX-2-mediated inflammatory nociception follow-
ing joint immobilization.
In addition, qualitative and quantitative changes in
connective tissue are believed to be a leading candidate
as the cause of myogenic contracture [1, 29]. Endo- and
perimysial connective tissue have been shown to in-
crease in the rat soleus muscle when immobilized for
3 weeks [38, 39]. Perimysial collagen fibril arrangement
also alters in immobilized rat soleus muscles [38] with a
concomitant reduction in joint ROM [3]. In the
present study, the sarcomere length at a stretched
position, which is theoretically inhibited by the con-
nective tissue surrounding the muscle fibers and
A B C
D E F
Fig. 5 Morphological changes in the knee joint. Representative images of the posterior region of the knee with Hematoxylin and Eosin stain in the control
group (a, d), Im group (b, e), and Im+ BTX group (c, f). Higher magnification of the squared areas in a, c, and e, are shown in b, d, and f, respectively. In
the control group, blood cell infiltration was hardly visible in the joint space at inferior capsule-cartilage junctions. In the Im and Im +
CBX groups, comparable amounts of red blood cells were present (arrows). g Box plot showing mean values of intra-articular hemorrhage
scores. Celecoxib treatment did not prevent joint hemorrhage induced by joint immobilization. *P < 0.05 compared with control. h Histogram showing
posterior synovial lengths. Celecoxib treatment did not prevent the reduction of synovial length induced by joint immobilization. *P < 0.05 compared
with control. Data are expressed as means ± SD (n = 10)
Table 2 Hemorrhage scores in each part of the knee joint
cavity
Group Antero- Postero- Average
Superior Inferior Superior Inferior
Control 0.5 ± 0.5 0.5 ± 0.5 0.6 ± 0.5 0.5 ± 0.5 0.5 ± 0.4
Im 1.8 ± 0.8† 1.6 ± 0.5† 2.3 ± 1.1† 1.4 ± 1.0† 1.8 ± 0.6†
Im + CBX 1.5 ± 0.8† 1.3 ± 0.8† 2.0 ± 0.8† 1.7 ± 1.1† 1.8 ± 0.6†
Values are shown as means ± SD
† indicates significant difference from Control (P < 0.05)
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bundles, was unaltered by joint immobilization. How-
ever, this result does not necessarily deny the involve-
ment of intramuscular connective tissue in muscle
extensibility. The semitendinosus muscles were pulled
by a weight of 16 g, and a stronger or weaker trac-
tion was not tested. In addition, changes in mechan-
ical properties may occur in non-semitendinosus
muscle, or in sliding between adjacent muscles. Thus,
further study is needed to determine the full effects
of celecoxib on the volume and mechanical properties
of intramuscular collagen.
Celecoxib had no effect on arthrogenic contracture,
unlike myogenic contracture. Trudel et al. [4] noted that
structural reorganization in the joint posterior capsule
(shortening due to adhesion between folds, type I colla-
gen deposition, and advanced glycation end products) is
responsible for arthrogenic joint contracture following
long-lasting (>4 weeks) joint immobilization in flexion
[4]. In this study, the lengths of the posterior capsules
were comparably shortened in both Im and Im + CBX
groups. Celecoxib had no effect on arthrogenic contrac-
ture formation, which may be due to a failure to inhibit
the shortening of the joint capsule. This result also sug-
gests that the joint capsule length may be shortened by
joint immobilization regardless of the inflammation.
Several studies report that the prevention of arthro-
genic contracture is achieved by intraarticular injection
of decorin, which inhibits the activity of transforming
growth factor-beta [40], hyaluronic acid [21, 22], myto-
mycin C [41], and celecoxib [42]. These previous reports
used animal models of traumatic contracture or a com-
bination of joint trauma and immobilization, both of
which show prominent inflammatory changes in affected
joints, unlike in an immobilized model. In an immobilized
model, arthrogenic contracture is alleviated by intra-
articular injection of corticosteroid triamcinolone in rats
[43]. However, as an adverse effect, triamcinolone-treated
rat joints showed a disruption with a significantly lighter
weight load than the untreated control. A recent study
showed that intra-articular injection of hyaluronan could
prevent fibrotic and inflammatory changes in immobilized
joint capsules [21]. Exogenous hyaluronan treatment stim-
ulates hyaluronan synthesis and reduces pro-inflammatory
mediators in osteoarthritic joints [44]. The reason for this
discrepancy between celecoxib and hyaluronan remain
unexplained. Actions except anti-inflammation of hyalur-
onan, e.g., hydrodynamic changes, might be in part due to
inhibit arthrogenic contracture.
Interestingly, microscopic observation revealed that
intra-articular hemorrhages increased comparably in both
Im and Im +CBX groups compared to the control. To test
the possibility of developing joint damage caused by the
mechanical stress during ROM measurement, we per-
formed histological observation in three-week-immobilized
knee joints without ROM measurement, additively (n = 2).
The observation confirmed that joint immobilization itself
contributes to bleeding. Coagulating blood not only induces
joint damage [45] but also accelerates immobilization-
induced synovial adhesions and capsular shortening in rats
[28]. The mechanism of joint hemorrhage induced by joint
immobilization is unknown. However, if it is possible to
prevent joint hemorrhage during immobilization, arthro-
genic joint contracture might be alleviated.
Generally, passive movement is used as a strategy for
the treatment of joint contracture. However, joint move-
ment cannot be done in acute post-surgery phases or for
orthopedic diseases such as joint fractures, muscle, and
ligament injuries. In addition, it is not clear whether
these interventions are clinically effective on joint mobil-
ity [9, 10]. An important finding of this study is that
even immobilization-induced contracture can be attenu-
ated by oral administration of celecoxib, which is advan-
tageous because it can be provided during periods of
immobilization. This suggests that anti-inflammatory
drug celecoxib is a possible option for the prevention of
joint contracture followed by immobilization.
There are several limitations to the study. First, we ob-
served the effects of joint immobilization and celecoxib
treatment on joint contracture formation at only one
time point. However, changes in the degree of contribution
of both articular and muscle components in joint contrac-
ture formation depend on the period of immobilization [4].
Second, we measured the ROMs with only a single load,
not an escalating load which provide a more detailed ana-
lysis of immobility. Third, administration of celecoxib in
this study (50 mg/kg dose) is approximately 10X higher
than that used by humans. In addition, the half-life for cel-
ecoxib in male rats is significantly shorter than that in hu-
man (3.7 h vs 11 h) [46]. Fourth, COX-2 activity was not
measured to confirm drug efficacy and we did not investi-
gate the roles of COX-2 pathways on the formation of joint
contracture. In addition, we have not directly shown the
anti-inflammatory effects of Celecoxib in immobilized
joints. Therefore, whether this celecoxib efficacy could be
extended for clinical use of joint contracture still requires
further studies.
Conclusions
The present study revealed that the oral administration
of COX-2 inhibitor celecoxib partially reduced myogenic
ROM restriction concomitantly with knee flexor muscle
shortening following immobilization. This result implies
that inflammation and nociception are involved in
myogenic contracture formation independently of joint
immobilization. Celecoxib had a significant efficacy for
prevention of joint contracture following immobilization
in a rat model.
Ozawa et al. BMC Musculoskeletal Disorders  (2016) 17:446 Page 8 of 10
Abbreviations
CBX: Celecoxib; COX: Cyclooxygenase; HE: Hematoxylin and eosin;
Im: Immobilization; NSAID: Non-steroidal anti-inflammatory drug;
ROM: Range of motion
Acknowledgements
Special thanks to Seiichi Kawamata and Tomoyuki Kurose (Hiroshima
University) for their advice and expertise. We also acknowledge the technical
assistance of Kengo Minamimoto, Nodoka Eguchi, Shunsuke Wakisaka, Yuta
Sakamoto, Shogo Takagi, Koji Takagaki, Akie Koshi, and Haruna Motokawa
(Hiroshima International University).
Funding
Financial support of this study was provided by the Department of Rehabilitation,
Faculty of Rehabilitation, Hiroshima International University and a Grant-in-Aid for
Scientific Research from the Ministry of Education, Culture, Sport, Science, and
Technology of Japan #22700564.
Availability of data and materials
All the data supporting our findings is contained within the manuscript.
Authors’ contributions
JO contributed to the study design and the analysis and interpretation of
data. JO, AK, and RT contributed to the acquisition of data. JO, NK, and HM
contributed to the manuscript preparation. All authors read and approved
the final manuscript.
Competing interest




This study was carried out upon receiving approval by the Committee of
Research Facilities for Laboratory Animal Sciences at Hiroshima International
University (permission number: AE10-010).
Author details
1Department of Rehabilitation, Faculty of Rehabilitation, Hiroshima
International University, Kurose- Gakuendai 555-36, Higashi-Hiroshima,
Hiroshima 739-2695, Japan. 2Graduate School of Medical Technology and
Health Welfare Sciences, Hiroshima International University,
Higashi-Hiroshima, Hiroshima, Japan. 3Department of Rehabilitation Science,
Graduate School of Health Sciences, Kobe University, Tomogaoka 7-10-2,
Suma-ku, Kobe, Hyogo, Japan.
Received: 10 December 2015 Accepted: 17 October 2016
References
1. Farmer SE, James M. Contractures in orthopaedic and neurological
conditions: a review of causes and treatment. Disabil Rehabil. 2001;23(13):
549–58.
2. Okita M, Nakano J, Kataoka H, Sakamoto J, Origuchi T, Yoshimura T. Effects
of therapeutic ultrasound on joint mobility and collagen fibril arrangement
in the endomysium of immobilized rat soleus muscle. Ultrasound Med Biol.
2009;35(2):237–44.
3. Okita M, Yoshimura T, Nakano J, Motomura M, Eguchi K. Effects of reduced
joint mobility on sarcomere length, collagen fibril arrangement in the
endomysium, and hyaluronan in rat soleus muscle. J Muscle Res Cell Motil.
2004;25(2):159–66.
4. Trudel G, Laneuville O, Coletta E, Goudreau L, Uhthoff HK. Quantitative and
temporal differential recovery of articular and muscular limitations of knee
joint contractures; results in a rat model. J Appl Physiol. 2014;117(7):730–7.
5. Usuba M, Akai M, Shirasaki Y, Miyakawa S. Experimental joint contracture
correction with low torque–long duration repeated stretching. Clin Orthop
Relat Res. 2007;456:70–8.
6. Usuba M, Miyanaga Y, Miyakawa S, Maeshima T, Shirasaki Y. Effect of heat in
increasing the range of knee motion after the development of a joint
contracture: an experiment with an animal model. Arch Phys Med Rehabil.
2006;87(2):247–53.
7. Hildebrand KA, Zhang M, Germscheid NM, Wang C, Hart DA. Cellular, matrix,
and growth factor components of the joint capsule are modified early in
the process of posttraumatic contracture formation in a rabbit model. Acta
Orthop. 2008;79(1):116–25.
8. Furia JP, Willis FB, Shanmugam R, Curran SA. Systematic review of
contracture reduction in the lower extremity with dynamic splinting. Adv
Ther. 2013;30(8):763–70.
9. Prabhu RK, Swaminathan N, Harvey LA. Passive movements for the
treatment and prevention of contractures. Cochrane Database Syst Rev.
2013;12:CD009331.
10. Katalinic OM, Harvey LA, Herbert RD. Effectiveness of stretch for the
treatment and prevention of contractures in people with neurological
conditions: a systematic review. Phys Ther. 2011;91(1):11–24.
11. Kaneguchi A, Ozawa J, Kawamata S, Kurose T, Yamaoka K. Intermittent whole-
body vibration attenuates a reduction in the number of the capillaries in
unloaded rat skeletal muscle. BMC Musculoskelet Disord. 2014;15:315.
12. Kaneguchi A, Ozawa J, Moriyama H, Yamaoka K. Structures responsible for
the formation of knee joint contracture secondary to adjuvant-induced
arthritis in a rat model. Iryoukougaku Zasshi. 2015;9:1–12.
13. Michelsson JE, Hunneyball IM. Inflammatory involvement in rabbit knee
following immobilization and resulting in osteoarthritis. Scand J Rheumatol.
1984;13(3):273–81.
14. Yabe Y, Hagiwara Y, Suda H, Ando A, Onoda Y, Tsuchiya M, Hatori K, Itoi E.
Joint immobilization induced hypoxic and inflammatory conditions in rat
knee joints. Connect Tissue Res. 2013;54(3):210–7.
15. Hashmi JA, Yashpal K, Holdsworth DW, Henry JL. Sensory and vascular
changes in a rat monoarthritis model: prophylactic and therapeutic effects
of meloxicam. Inflamm Res. 2010;59(8):667–78.
16. Kaur S, Bijjem KR, Sharma PL. Anti-inflammatory and antihyperalgesic effects
of the combination of ibuprofen and hemin in adjuvant-induced arthritis in
the Wistar rat. Inflammopharmacology. 2011;19(5):265–72.
17. Laird JM, Herrero JF, Garcia de la Rubia P, Cervero F. Analgesic activity of
the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: central
and peripheral components. Inflamm Res. 1997;46(6):203–10.
18. Michelsson JE, Juntunen S, Valtakari T. Methylprednisolone has a preventive effect
on the development of radiological changes, thickening and stiffening of the
rabbit knee following immobilization. Clin Orthop Relat Res. 1990;8(5):439–43.
19. Michelsson JE. The effect of ibuprofen on the thickening, stiffening and
development of degenerative changes in the rabbit knee following
immobilization. Scand J Rheumatol. 1980;9(3):141–4.
20. Trudel G, Uhthoff HK. Contractures secondary to immobility: is the
restriction articular or muscular? An experimental longitudinal study in the
rat knee. Arch Phys Med Rehabil. 2000;81(1):6–13.
21. Kanazawa K, Hagiwara Y, Tsuchiya M, Yabe Y, Sonofuchi K, Koide M,
Sekiguchi T, Itaya N, Ando A, Saijo Y, et al. Preventing effects of joint
contracture by high molecular weight hyaluronan injections in a rat
immobilized knee model. Int J Clin Exp Pathol. 2015;8(4):3426–40.
22. Wang M, Liu C, Xiao W. Intra-articular injection of hyaluronic acid for the
reduction in joint adhesion formation in a rabbit model of knee injury. Knee
Surg Sports Traumatol Arthrosc. 2014;22(7):1536–40.
23. Zweers MC, de Boer TN, van Roon J, Bijlsma JW, Lafeber FP, Mastbergen SC.
Celecoxib: considerations regarding its potential disease-modifying
properties in osteoarthritis. Arthritis Res Ther. 2011;13(5):239.
24. Nagai M, Aoyama T, Ito A, Iijima H, Yamaguchi S, Tajino J, Zhang X, Akiyama
H, Kuroki H. Contributions of biarticular myogenic components to the
limitation of the range of motion after immobilization of rat knee joint. BMC
Musculoskelet Disord. 2014;15:224.
25. Moriyama H, Tobimatsu Y, Ozawa J, Kito N, Tanaka R. Amount of torque and
duration of stretching affects correction of knee contracture in a rat model
of spinal cord injury. Clin Orthop Relat Res. 2013;471(11):3626–36.
26. Ando A, Suda H, Hagiwara Y, Onoda Y, Chimoto E, Itoi E. Remobilization
does not restore immobilization-induced adhesion of capsule and restricted
joint motion in rat knee joints. Tohoku J Exp Med. 2012;227(1):13–22.
27. Moriyama H, Yoshimura O, Kawamata S, Takemoto H, Saka Y, Tobimatsu Y.
Alteration of knee joint connective tissues during contracture formation in
spastic rats after an experimentally induced spinal cord injury. Connect
Tissue Res. 2007;48(4):180–7.
28. Onoda Y, Hagiwara Y, Ando A, Watanabe T, Chimoto E, Suda H, Yabe Y,
Saijo Y, Itoi E. Joint haemorrhage partly accelerated immobilization-induced
Ozawa et al. BMC Musculoskeletal Disorders  (2016) 17:446 Page 9 of 10
synovial adhesions and capsular shortening in rats. Knee Surg Sports
Traumatol Arthrosc. 2014;22(11):2874–83.
29. Gajdosik RL. Passive extensibility of skeletal muscle: review of the literature
with clinical implications. Clin Biomech. 2001;16(2):87–101.
30. Bondesen BA, Mills ST, Kegley KM, Pavlath GK. The COX-2 pathway is
essential during early stages of skeletal muscle regeneration. Am J Physiol
Cell Physiol. 2004;287(2):C475–83.
31. Shen W, Prisk V, Li Y, Foster W, Huard J. Inhibited skeletal muscle healing in
cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha.
J Appl Physiol. 2006;101(4):1215–21.
32. Novak ML, Billich W, Smith SM, Sukhija KB, McLoughlin TJ, Hornberger TA,
Koh TJ. COX-2 inhibitor reduces skeletal muscle hypertrophy in mice.
Am J Physiol Regul Integr Comp Physiol. 2009;296(4):R1132–9.
33. Bondesen BA, Mills ST, Pavlath GK. The COX-2 pathway regulates growth of
atrophied muscle via multiple mechanisms. Am J Physiol Cell Physiol. 2006;
290(6):C1651–9.
34. Tabary JC, Tardieu C, Tardieu G, Tabary C. Experimental rapid sarcomere loss
with concomitant hypoextensibility. Muscle Nerve. 1981;4(3):198–203.
35. Huet de la Tour E, Tardieu C, Tabary JC, Tabary C. Decrease of muscle
extensibility and reduction of sarcomere number in soleus muscle following
a local injection of tetanus toxin. J Neurol Sci. 1979;40(2–3):123–31.
36. Yamashita I, Atsuta Y, Shimazaki S, Miyatsu M. [Effects of prostaglandin E2
and sodium hyaluronate on bradykinin induced knee joint pain in rat].
Nihon Seikeigeka Gakkai Zasshi. 1995;69(9):735–43.
37. Trudel G, Desaulniers N, Uhthoff HK, Laneuville O. Different levels of COX-1
and COX-2 enzymes in synoviocytes and chondrocytes during joint
contracture formation. J Rheumatol. 2001;28(9):2066–74.
38. Jarvinen TA, Jozsa L, Kannus P, Jarvinen TL, Jarvinen M. Organization and
distribution of intramuscular connective tissue in normal and immobilized
skeletal muscles. An immunohistochemical, polarization and scanning
electron microscopic study. J Muscle Res Cell Motil. 2002;23(3):245–54.
39. Jozsa L, Thoring J, Jarvinen M, Kannus P, Lehto M, Kvist M. Quantitative
alterations in intramuscular connective tissue following immobilization: an
experimental study in the rat calf muscles. Exp Mol Pathol. 1988;49(2):267–78.
40. Fukui N, Fukuda A, Kojima K, Nakajima K, Oda H, Nakamura K. Suppression of
fibrous adhesion by proteoglycan decorin. J Orthop Res. 2001;19(3):456–62.
41. Kocaoglu B, Akgun U, Nalbantoglu U, Poyanli O, Karahan M. Adhesion
reduction after knee surgery in a rat model by mitomycin C. Knee Surg
Sports Traumatol Arthrosc. 2011;19(1):94–8.
42. Li F, He B, Liu S, Fan C. Celecoxib effectively inhibits the formation of joint
adhesions. Exp Ther Med. 2013;6(6):1507–11.
43. Clark DD, Weckesser EC. The influence of triamcinolone acetonide on joint
stiffness in the rat. J Bone Joint Surg Am. 1971;53(7):1409–14.
44. Migliore A, Procopio S. Effectiveness and utility of hyaluronic acid in
osteoarthritis. Clin Cases Miner Bone Metab. 2015;12(1):31–3.
45. van Meegeren ME, Roosendaal G, Barten-van Rijbroek AD, Schutgens RE,
Lafeber FP, Mastbergen SC. Coagulation aggravates blood-induced joint
damage in dogs. Arthritis Rheum. 2012;64(10):3231–9.
46. Paulson SK, Zhang JY, Breau AP, Hribar JD, Liu NW, Jessen SM, Lawal YM,
Cogburn JN, Gresk CJ, Markos CS, et al. Pharmacokinetics, tissue distribution,
metabolism, and excretion of celecoxib in rats. Drug Metab Dispos. 2000;
28(5):514–21.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ozawa et al. BMC Musculoskeletal Disorders  (2016) 17:446 Page 10 of 10
